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Abstract
Background
Panic disorder (PD) is associated with impaired functioning and reduced quality of life. In the
Netherlands, almost 2% of the population experiences clinically relevant panic symptoms
without meeting the diagnostic criteria for PD, which is referred to as subthreshold PD
(STHPD). Evidence suggests that subthreshold mental disorders may have a similar impact
on quality of life and functioning in comparison with full-blown mental disorders, which
draws attention to the need for interventions for STHPD. These interventions are currently
not systematically provided in clinical practice. This study aims to investigate the population
cost-effectiveness of adding a CBT-based early intervention for adults with STHPD to the
existing health care for people with PD in the Netherlands.
Methods
A health-economic Markov model was constructed in order to compare quality adjusted life-
years (QALYs) and societal costs of adding an early intervention to usual care for PD. The
model compares usual care with an alternative program in which usual care is supple-
mented with a CBT-based early intervention. Input parameters for the model were derived
from national sources and published literature where possible, and based on expert opinion
otherwise. Probabilistic and deterministic sensitivity analyses were conducted to evaluate
the uncertainty of the model input parameters.
Results
On average, the added CBT-based early intervention was dominant in comparison with
usual care, meaning that the early intervention yielded more QALYs at lower costs. At a
PLOS ONE | https://doi.org/10.1371/journal.pone.0193338 February 21, 2018 1 / 14
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Ophuis RH, Lokkerbol J, Hiligsmann M,
Evers SMAA (2018) Early intervention for
subthreshold panic disorder in the Netherlands: A
model-based economic evaluation from a societal
perspective. PLoS ONE 13(2): e0193338. https://
doi.org/10.1371/journal.pone.0193338
Editor: Mary Lou Chatterton, Deakin University,
AUSTRALIA
Received: May 15, 2017
Accepted: January 30, 2018
Published: February 21, 2018
Copyright: © 2018 Ophuis et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
willingness-to-pay threshold of €20,000 per QALY, the cost-effectiveness probability of the
added early intervention was 98%. Sensitivity analyses showed that the results were robust.
Conclusions
This study showed that offering an early intervention in addition to usual care for PD is
potentially cost-effective, but it should be further investigated to what extent trial results can
be extrapolated to the level of the population before such interventions are implemented on
a large scale.
Introduction
Panic disorder (PD) is a disabling anxiety disorder that is associated with impaired functioning
and reduced quality of life [1, 2]. Individuals with PD experience unexpected panic attacks
characterized by symptoms such as hyperventilation, palpitations and derealisation [3]. Impor-
tant characteristics of PD are the avoidance of potential anxiety-provoking situations and the
anticipated fear of having future panic attacks [3].
PD is associated with medically unexplained symptoms and high healthcare utilization [4,
5]. On average, individuals who experience panic symptoms visit general practitioners, medi-
cal specialists, and emergency departments more often than the general population [6].
About 2% of the Dutch population experiences clinically relevant panic symptoms without
meeting the diagnostic criteria of a full-blown PD diagnosis [7]. This subclinical form of PD is
generally referred to as subthreshold PD (STHPD) [8]. In the Netherlands, STHPD is almost
as prevalent as full-blown PD (1.9% versus 2.2%) [7].
As a result of the currently applied diagnostic thresholds for PD, many individuals with
clinically relevant symptoms might not receive appropriate treatment [9], which could lead to
progression of morbidity and deterioration of quality of life resulting in full-blown PD [10,
11]. Studies have shown that subthreshold mental disorders may have a similar impact on
quality of life and functioning on the level of the population in comparison with full-blown
mental disorders due to a higher prevalence of subthreshold disorders [9, 11]. Although the
STHPD prevalence in the Netherlands is lower than the prevalence of PD, the health impact
and costs of STHPD are substantial.
The societal per capita costs for PD and STHPD in the Netherlands are respectively €8,000–
10,000 and €6,000 per year [7, 12]. The indirect non-medical costs for PD and STHPD are
both higher than the indirect non-medical costs for phobias, social anxiety disorder, and gen-
eralized anxiety disorder [12], which shows that that PD and STHPD are both associated with
substantial productivity losses. The relatively high prevalence rate and societal costs of STHPD
emphasize that there is a treatment need.
Various psychological and pharmacological interventions for PD have been shown to be
effective and cost-effective [13–15], but the evidence on the effectiveness and cost-effectiveness
of interventions for treating STHPD is less substantial. Meulenbeek et al. [16] showed that a
cognitive behavioral therapy (CBT) based early intervention for adults with STHPD signifi-
cantly reduced panic symptoms. This intervention called ‘Don’t Panic’ is group-based. An
economic evaluation of this intervention resulted in an incremental cost-effectiveness ratio
(ICER) of €6,000 per PD-free survival gained when compared to usual care [17].
Although these studies [16, 17] show promising results in terms of effectiveness, early inter-
ventions for treating STHPD are currently not systematically offered in Dutch clinical practice.
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Before such interventions can be implemented in clinical practice, further evidence on the
cost-effectiveness at the population level is essential for policy makers. A health-economic
model can contribute to such evidence. Therefore, this study aims to investigate the population
cost-effectiveness of adding a CBT-based early intervention for adults with STHPD to the
existing health care for people with PD in the Netherlands by means of a health-economic
Markov model.
Methods
The methods and reporting of this model-based economic evaluation are in concordance with
the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement and
ISPOR recommendations [18, 19]. A completed CHEERS checklist has been added to the
appendix (S1 Table).
Study population and epidemiology
The study population in the model comprised the Dutch adult population aged 18–65 years
[20, 21]. Prevalence and incidence estimates of PD and STHPD were obtained from the Neth-
erlands Mental Health Survey and Incidence Study, a cohort study on the epidemiology of
mental disorders in the Dutch general population [22]. The annual prevalence rates of PD and
STHPD were respectively 2.2% (95%CI 1.9–2.6) and 1.9% (95%CI 1.6–2.2) [9]. DSM-III-R
diagnostic criteria for PD were applied. STHPD was defined as having at least one experience
of panic during the last year in a situation in which the panic attack is not considered normal
[9]. This experience must have been accompanied by at least four of the thirteen panic symp-
toms according to the DSM-III-R, and may not be of organic cause.
The annual incidence of PD in the Netherlands was 0.52% (95%CI 0.37–0.73) [23]. Within
two years, 43.3% of the PD patients and 23.8% of the STHPD patients had chronic panic com-
plaints, whereas respectively 21.4% and 37% of the STHPD patients who reached remission
had a recurrence [24].
Usual care
The usual care scenario (Table 1) reflects usual care for PD in the Netherlands. We assumed
that the recommended interventions as described in Dutch multidisciplinary treatment guide-
line for anxiety disorders [25] represent current clinical practice.
Recommended psychological interventions for PD are therapist-led interventions based on
cognitive or behavioral therapy [25]. In Dutch clinical practice, these interventions are gener-
ally offered combined as CBT. Therefore, CBT was considered as psychological intervention in
the model. We defined CBT as a psychological intervention based on learning theory and cog-
nitive restructuring [26].
Table 1. Base-case and alternative scenario.
Intervention Uptake usual care (%) Uptake additional CBT-based early intervention (%) Adherence (%)
PD
CBT 8.8 8.8 70
SSRI 9.2 9.2 57
TCA 2.4 2.4 49
Combination therapy 9.0 9.0 70
STHPD
CBT-based early intervention 0 10 70
https://doi.org/10.1371/journal.pone.0193338.t001
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Selective serotonin inhibitors (SSRIs) are first-choice pharmacotherapy for PD and tricyclic
antidepressants (TCAs) are second-choice pharmacotherapy [25]. Both SSRIs and TCAs were
added to the model as pharmacological interventions. SSRIs are first-choice pharmacotherapy
as they are generally better tolerated and cause fewer adverse events in comparison with TCAs
[25].
Furthermore, combination therapy consisting of pharmacological treatment and CBT was
added to the model. Benzodiazepines were not considered because they are only recom-
mended for acute and situation-specific treatment [25].
Additional CBT-based early intervention
In order to investigate the additional effect of adding an early intervention for STHPD to the
current clinical practice for PD in the Netherlands, usual care was supplemented with an early
intervention for treating STHPD (Table 1).
The early intervention in the model was based on the ‘Don’t Panic’ intervention described
by Meulenbeek et al. [16] and Smit et al. [17]. The early intervention is a CBT-based group
course for adults aged eighteen years and older (6–12 participants) with STHPD. The group
course consists of eight weekly sessions of two hours guided by a prevention worker and a
mental health clinician. The group course covers psycho-education, lifestyle advice, stress cop-
ing, cognitive restructuring, in vivo exposure, and a relapse prevention training.
Intervention uptake and adherence
In the Netherlands, 29.4% of the PD patients utilize mental health care [27]. As it is not known
how often specific interventions for PD are offered, we used Australian data regarding mental
health care utilization as an approximation [28]. Based on expert opinion, respectively 85%
and 15% of the Dutch PD patients receiving pharmacotherapy use SSRIs and TCAs, of which
one third receives combination therapy (both pharmacotherapy and CBT) due to unsuccessful
treatment outcomes. Because early interventions are currently not offered systematically in the
Netherlands, the uptake in usual care is set at 0%. In the scenario with the added CBT-based
early intervention, the uptake rate for the early intervention is set at 10%. For the remaining
interventions, we applied equal uptake rates.
We applied an adherence rate of 70% for all interventions considered in the model, assum-
ing that the effectiveness of interventions in clinical practice is generally lower than in clinical
trials. Additionally, we applied drop-out rates for SSRI and TCA treatment (respectively 18%
and 30%) based on the Dutch multidisciplinary guideline for anxiety disorders [25], resulting
in lower adherence rates. We conservatively assumed that non-adherent patients had no utility
gain (no effect of treatment). Full intervention costs were incurred for non-adherent patients.
Table 1 describes the uptake and adherence rates for usual care and the early intervention
scenario.
Structural assumptions
A four-state Markov model was constructed using Microsoft Excel 2013 in order to assess the
incremental costs and quality adjusted life-years (QALYs) of the added CBT-based early inter-
vention versus usual care. The model structure, as depicted in Fig 1, is based on the availability
of epidemiological and clinical evidence. The cycle length was one year, corresponding to the
available epidemiological evidence, which generally reports annual transition rates. Subjects
either remain in the same health state or switch to a connecting health state, assuming that
only one switch per cycle is possible. We applied a time horizon of five years.
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Four mutually exclusive health states were considered in the model; panic-free (PF),
STHPD, PD, and death. Individuals who neither met the earlier mentioned diagnostic criteria
for PD and STHPD were in the PF health state. We assumed that STHPD was intermediate
between PF and PD, meaning that individuals with PD can only reach the PF state by crossing
the STHPD health state and vice versa. This assumption implies that the incidence of PD solely
occurs from STHPD.
Model parameters
Health state utilities. The effectiveness of the interventions was expressed in QALYs,
which required the use of utility scores of the included health states. A utility score reflects
health-related quality of life ranging from 0 (death) to 1 (full health). Utility values can be mul-
tiplied by their duration in years to calculate QALYs. One QALY gained reflects one extra life-
Fig 1. Markov model structure.
https://doi.org/10.1371/journal.pone.0193338.g001
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year in full health gained. For the individuals who were not diagnosed with (STH)PD, we used
a published utility score of the Dutch general population [29]. Utility data for the PD health
state were derived from the European Study of the Epidemiology of Mental Disorders [30].
The utility score for the STHPD health state was derived from a Dutch disability weight study
[31]. All utility scores were based on the EQ-5D. STHPD and PD utilities were multiplied with
the general population utility in order to ensure that improvements from STHPD and PD to
PF reflected utility gains as expected by burden of disease studies [30, 31]. This adjustment was
deemed necessary to improve the comparability of health state utility values taken from differ-
ent sources. In a sensitivity analysis, we investigate the impact of this correction. The health
state utilities are reported in Table 2, alongside with the other parameter values.
Health gains. Interventions aim to increase utility and thereby QALYs. In the model,
QALY gains due to interventions aimed at treating PD were based on effect sizes from a recent
meta-analysis on interventions for anxiety disorders [14]. The effect size of the early interven-
tion was based on trial data [16]. Effect sizes were converted to utility gains by means of a con-
version method described by Sanderson et al [34]. The effect sizes and conversion values are
presented in the appendix (S2 Table). The preventive effect of the early intervention on pro-
gression from STHPD to PD, expressed as a decrease in the transition rate from SHPD to PD,
was based on the study by Meulenbeek et al. [16].
Transition probabilities. Transition probabilities in terms of incidence, recurrence, and
chronicity as described earlier reflect usual care since they were based on cohort studies in
which participants had no restrictions in terms of healthcare resources. Ideally, intervention
specific transition probabilities are included in the model. We used intervention specific prob-
abilities for the early intervention, but not for the remaining interventions due to a limited
availability of evidence.
Resource use and cost data. Direct medical costs, direct non-medical costs, and indirect
non-medical costs for the PD and STHPD health states were derived from a cost-of-illness
study by Batelaan et al [7]. The authors were contacted for a detailed overview of the cost cate-
gories. Direct medical costs relate directly to medical care, such as doctor visits. Direct non-
medical costs are out-of-pocket costs, for example travel costs due to doctor visits. Indirect
non-medical costs consist of costs due to productivity losses. We calculated the societal costs
by summing up the direct medical costs, direct non-medical costs, and indirect non-medical
costs. All costs are expressed in euros (€) for the reference-year 2014. We used the Dutch price
index (Central Bureau of Statistics, the Netherlands) in order to express costs in 2014 euros.
Intervention specific costs. Unit cost prices were obtained from the Dutch Guideline for
Health Economic Evaluations [32]. Costs for medication were based on Dutch reimbursement
rates [35]. The intervention-specific resource use is described in Table 2.
The costs for the early intervention were derived from the economic evaluation of the
‘Don’t panic’ intervention by Smit et al. [17]. The intervention costs were €905 per patient
(indexed for the year 2014). The intervention consists of eight CBT sessions of two hours each
by a prevention worker and a clinician, followed by one booster session three months after
completion.
Cost-effectiveness analysis. Mean costs and QALYs were estimated for usual care and the
added CBT-based early intervention. Both costs and effects were discounted annually. The
incremental cost-effectiveness ratio (ICER) was calculated by dividing the difference in costs
between both scenarios by the difference in QALYs. The ICER represents the cost of an addi-
tional life-year in full health gained. A cost-effectiveness acceptability curve was plotted, which
shows the probability that the added early intervention is cost-effective for different willing-
ness-to-pay (WTP) thresholds. The early intervention was deemed cost-effective when the
ICER is below the WTP-threshold of €20,000 per QALY, a threshold for disorders with
Early intervention for subthreshold panic disorder in the Netherlands
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disability weights between 0.1 and 0.4 according to the Dutch Healthcare Institute recommen-
dations [36].
Handling uncertainty. A probabilistic sensitivity analysis was performed in order to take
into account the uncertainty surrounding the point estimates of the input parameters.
Table 2. Model input parameters.
Input parameter Deterministic value Probabilistic distribution Source
Discount rate costs 4% Fixed Dutch Guideline for Health Economic Evaluations [32]
Discount rate outcomes 1.5% Fixed Dutch Guideline for Health Economic Evaluations [32]
Indirect non-medical costs per health state (annual)
PF €6,643 Gamma Based on data by Batelaan et al. and Smit et al. [7, 12]
STHPD €9,741 Gamma Based on data by Batelaan et al. [7]
PD €16,771 Gamma Based on data by Batelaan et al. [7]
Direct medical costs (annual)
PF €340 Gamma Based on data by Batelaan et al. [7]
STHPD €1,503 Gamma Based on data by Batelaan et al. [7]
PD €666 Gamma Based on data by Batelaan et al. [7]
Direct non-medical costs (annual)
PF €99 Gamma Based on data by Batelaan et al. [7]
STHPD €494 Gamma Based on data by Batelaan et al. [7]
PD €858 Gamma Based on data by Batelaan et al. [7]
Health state utilities
PF 0.869 Normal, SE: 0.0054 [29]
STHPD 0.730 Normal, SE: 0.037 Based on Versteegh et al. [29] and Stouthard et al. [31]
PD 0.660 Normal, SE: 0.030 Based on Versteegh et al. [29] and Kaltenthaler et al. [30]
Transition probabilities
PF to STHPD 0.0016 Fixed Calculations based on epidemiology [7, 24]
STHPD to PF 0.0815 Fixed Calculations based on epidemiology [7, 24]
STHPD to PD 0.6037 Fixed Calculations based on epidemiology [7, 24]
STHPD to PD transition is lowered by the early intervention, based on a RR of 0.538 [16]
PD to STHPD 0.5214 Fixed Calculations based on epidemiology [7, 24]
Any state to ‘Death’ 0.0028 Fixed Based on Dutch national statistics, averaged for the population aged 18–65 years [33]
Utility gain after intervention
CBT 0.0327 Normal Based on Sanderson et al. [34] and Bandelow et al. [14]
SSRI 0.0450 Normal Based on Sanderson et al. [34] and Bandelow et al. [14]
TCA 0.0445 Normal Based on Sanderson et al. [34] and Bandelow et al. [14]
Combination therapy 0.0568 Normal Based on Sanderson et al. [34] and Bandelow et al. [14]
Early intervention 0.0655 Normal Based on Sanderson et al. [34] and Meulenbeek et al.[16]
Intervention costs (per person)
CBTa €1,176 Gamma [32], Expert opinion
SSRIb €1,128 Gamma [32], Expert opinion
TCAc €1,200 Gamma [32], Expert opinion
Combination therapyd €2,315 Gamma [32], Expert opinion
Early interventione €905 Gamma [17]
a12 sessions in Basic mental health care.
bDefined Daily Dose for one year (average SSRI costs) plus 9.5 sessions (min. 8 and max. 12) in specialized mental health care.
cDefined Daily Dose for one year (average TCA costs) plus 9.5 session in specialized mental health care.
d12 general mental health institution sessions, Defined Daily Dose for one year (average TCA/SSRI costs) plus 9.5 sessions in specialized mental health care.
eBased on Smit et al. [17] (explained in the Methods section).
https://doi.org/10.1371/journal.pone.0193338.t002
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Probability distributions were assigned to the parameters, after which 10,000 iterations were
performed by drawing random values for the input parameters. Utility parameters were
assigned a normal distribution, and cost parameters were assigned a gamma-distribution as
presented in Table 2. The mean incremental costs and QALYs were calculated by averaging
the 10,000 iterations.
Deterministic sensitivity analyses explored the impact of making several assumptions:
applying different uptake rates for the interventions, varying the effectiveness of the early
intervention, the use of alternative time horizons of one and ten years, and the use of utility
values that were not corrected for the baseline level of the general population.
Results
Over a period of five years, usual care resulted in 3.28 QALYs (95% CI 3.01–3.48) and €59,634
(95% CI 45,097–76,084) per patient on average, whereas the added CBT-based early interven-
tion resulted in 3.30 QALYs (95% CI 3.10–3.49) and €59,355 (95% CI 44,984–75,621) per
patient. All patients with STHPD and PD were included, regardless of whether they received
any intervention. When only the STHPD patients are considered, usual care resulted in 3.47
QALYs (95%CI 3.16–3.77) and €43,099 (95%CI 28,402–60,779) on average per STHPD
patient, and the added early intervention 3.58 QALYs (95%CI 3.27–3.89) and €44,512 (95%CI
29,448–62,668).
When both STHPD and PD patients are considered, the ICER equaled €-23,127 (95% CI
-395,731–3,682) per QALY gained, meaning that the added early intervention resulted in
more QALYs at lower costs on average in comparison with usual care. Fig 2 presents the cost-
effectiveness plane, in which the ICERs for the 10,000 iterations are depicted. The majority of
the ICERs were located in the lower-right quadrant of the incremental cost-effectiveness
plane, indicating dominance.
Fig 3 shows the cost-effectiveness acceptability curve, in which the probability that the
added early intervention is cost-effective in comparison with usual care is shown for a range of
WTP threshold values. When society is willing to pay €20,000 per QALY, the cost-effectiveness
probability of the added CBT-based early intervention is 98%.
Multiple one-way sensitivity analyses were performed in order to assess the robustness of
the results. Table 3 reports the ICERs after altering different key parameters. All ICERs
resulted on average in more QALYs at lower costs, indicating that the addition of the CBT-
based early intervention is cost-saving on average. The confidence intervals of the reference
case and sensitivity analyses ICERs indicate that there is a minimal chance that the added
intervention will result in higher costs compared to usual care. However, these upper limits
are far below the WTP threshold of €20,000 per QALY gained.
Discussion
Main findings
This study aimed to investigate the population cost-effectiveness of adding a CBT-based early
intervention for adults with STHPD to the existing health care for people with PD in the Neth-
erlands by means of a health-economic Markov model. Our main finding was that the added
early intervention for STHPD with 10% uptake yields more QALYs at lower costs on average
in comparison with usual care. When a WTP-threshold of €20,000 per QALY gained is
assumed, the cost-effectiveness probability of the added early intervention is 98%. Multiple
one-way sensitivity analyses supported this conclusion. Therefore, adding an early interven-
tion to the currently available interventions for PD potentially makes the care for (STH)PD in
the Netherlands more cost-effective from a societal perspective.
Early intervention for subthreshold panic disorder in the Netherlands
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Comparison with other published studies in the field
Earlier, the cost-effectiveness of an early intervention in comparison with usual care was inves-
tigated alongside a trial [17]. Although this intervention was cost-effective compared to usual
care, the cost-effectiveness of adding the intervention to usual care for PD at the level of the
population was not assessed. Furthermore, the time horizon of a trial-based economic evalua-
tions is relatively short. In the current study, the evidence on early interventions for STHPD
was extrapolated to the population level with an extended time horizon of five years.
A comparable study in the field of mental health reported that an early intervention for
patients at high risk for psychosis was also cost-saving in comparison with care as usual [37].
Our findings also suggest that offering an early intervention for STHPD has the potential to be
cost-saving. Since the current evidence base on the cost-effectiveness of early interventions for
STHPD is limited, more economic evaluations are needed to investigate the added value of
such interventions.
Strengths and limitations
The current study adds evidence on the cost-effectiveness of treating STHPD on the level of
the population. To our knowledge, this is the first health-economic model analyzing the cost-
effectiveness of adding an early intervention for STHPD to usual care for PD in the Nether-
lands. Available evidence regarding epidemiology, clinical effectiveness, and costs was
Fig 2. Incremental cost-effectiveness plane of the additional CBT-based early intervention versus usual care.
https://doi.org/10.1371/journal.pone.0193338.g002
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combined to support decision-making regarding the health care system for (STH)PD. The
model was designed to reflect clinical practice as closely as possible by taking into account
uptake rates and adherence rates. These rates can be altered manually in the model in order to
compare different scenarios.
Fig 3. Cost-effectiveness acceptability curve.
https://doi.org/10.1371/journal.pone.0193338.g003
Table 3. Results of the one-way sensitivity analyses.
ICER 95% CI
Mean (€) 2.5% 97.5%
Reference case -23,127 -395,731 3,682
Assumptions
Time horizon 1 year -14,529 -88,655 5,276
Time horizon 10 years -58,531 -165,535 -318
Early intervention 5% uptake rate -23,214 -372,735 3,521
Early intervention 15% uptake rate -23,113 -335,890 3,366
Early intervention transition from STHPD to PD 10% lower -18,507 -246,637 4,467
Early intervention transition from STHPD to PD 10% higher -28,351 -657,641 2,654
Uptake rate PD interventions 100% -20,706 -264,899 4,017
Uncorrected utility values -22,894 -314,488 3,593
https://doi.org/10.1371/journal.pone.0193338.t003
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Our study has several limitations. Ideally, model parameters are based on data reported in
meta-analyses rather than single trials. Because the current evidence base on the effectiveness
of early interventions for STHPD is limited, we derived effectiveness data for the early inter-
vention from a single RCT with a sample size of 217 [16]. Although the reported preventive
effect of the early intervention on the full-blown PD diagnostic status was significant, the effec-
tiveness of the CBT-based group intervention was investigated in one trial only. Further stud-
ies assessing the effectiveness of CBT-based early interventions are needed to confirm our
preliminary results.
Intervention-specific transitions were not applied for interventions for PD in the model
due to a lack of available evidence. This resulted in the assumption that patients who received
interventions for full-blown PD had the same chance of remission as patients who did not
receive treatment. Hence, the effect of the interventions for PD might have been underesti-
mated. However, the utility was increased as a result of receiving an intervention, which
yielded QALY gains for patients who received an intervention.
Comorbid conditions were not considered in the model, which we consider as a limitation.
For instance, it is known that panic is frequently comorbid with other anxiety disorders,
depression, and alcohol abuse [38, 39], which could lead to higher costs and lower quality of
life. The costs input parameters were corrected for comorbid mental disorders, meaning that
only the costs that can be attributed to (STH)PD were considered [7, 12]. Consequently, the
model does not take into account the possible effects of comorbid mental disorders on QALYs
and costs. Comorbid conditions might increase societal costs and lower quality of life for indi-
viduals with (STH)PD, but it is unclear whether the effectiveness of the early intervention for
STHPD is influenced by comorbid conditions.
Economic evaluations aim to identify the cost-effectiveness of interventions in order to
improve efficiency in healthcare systems. It should be noted that other factors should also be
taken into account in order to improve healthcare systems, such as patient preferences, feasi-
bility, and medical ethics [40]. However, the scope of this manuscript is restricted to the cost-
effectiveness perspective.
Recommendations
Because our findings suggest that adding a CBT-based early intervention for STHPD is poten-
tially cost-saving, policy makers should consider investing in the implementation of such
interventions. However, further high-quality research is needed on the comparative long-term
outcomes of early interventions as well as on costs and transition probabilities associated with
STHPD and PD in order to establish the relative cost-effectiveness of early interventions for
STHPD with greater certainty. Based on the study data of Batelaan et al. [17], the direct medi-
cal costs for individuals with STHPD were higher than the direct medical costs for individuals
with PD. Although these findings are based on a nationally representative study sample, fur-
ther studies are needed to support this finding. Finally, it should be emphasized that health-
economic modeling requires empirical validation. It is thus recommended that future studies
on early interventions for STHPD test the findings generated by the current model.
Conclusions
This study showed that offering an early intervention in addition to usual care for PD in the
Netherlands is potentially cost-saving. More research is needed on the comparative long-term
outcomes of early interventions as well as on costs and transition probabilities associated with
STHPD and PD in order to establish the relative cost-effectiveness of early interventions for
STHPD with greater certainty.
Early intervention for subthreshold panic disorder in the Netherlands
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